Primary Site >> Esophagus Cancer
Gene >> FCGR3A
| 1. | |||||||||||
| Journal: | Ann Surg Oncol. 2000 Sep;7(8):609-16. | ||||||||||
| Title: | Influence of multimodality therapy on the cellular immunity of patients with esophageal cancer. | ||||||||||
| Author: | Mafune, K|Tanaka, Y | ||||||||||
| PMID: | 11005560 | ||||||||||
| 2. | |||||||||||
| Journal: | Clin Cancer Res. 2000 Dec;6(12):4663-73. | ||||||||||
| Title: | Locoregional cellular immunotherapy for patients with advanced esophageal cancer. | ||||||||||
| Author: | Toh, U|Yamana, H|Sueyoshi, S|Tanaka, T|Niiya, F|Katagiri, K|Fujita, H|Shirozou, K|Itoh, K | ||||||||||
| PMID: | 11156218 | ||||||||||
| 3. | |||||||||||
| Journal: | Nutrition. 2011 Feb;27(2):146-52. | ||||||||||
| Title: | Immunonutritional diet modulates natural killer cell activation and Th17 cell distribution in patients with gastric and esophageal cancer. | ||||||||||
| Author: | Maruyama, Takanori|Mimura, Kousaku|Izawa, Shinichiro|Shiba, Shugo|Watanabe, Mitsuaki|Kawaguchi, Yoshihiko|Fujii, Hideki|Kono, Koji | ||||||||||
| PMID: | 21215924 | ||||||||||
| 4. | |||||||||||
| Journal: | Cancer Immunol Immunother. 2011 Dec;60(12):1801-10. | ||||||||||
| Title: | H(2)O(2) production within tumor microenvironment inversely correlated with infiltration of CD56(dim) NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction. | ||||||||||
| Author: | Izawa, Shinichirou|Kono, Koji|Mimura, Kousaku|Kawaguchi, Yoshihiko|Watanabe, Mitsuaki|Maruyama, Takanori|Fujii, Hideki | ||||||||||
| PMID: | 21811786 | ||||||||||
| 5. | |||||||||||
| Journal: | Front Immunol. 2018 Apr 19;9:814. | ||||||||||
| Title: | Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing gammadelta T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells. | ||||||||||
| Author: | Oberg, Hans H|Kellner, Christian|Gonnermann, Daniel|Sebens, Susanne|Bauerschlag, Dirk|Gramatzki, Martin|Kabelitz, Dieter|Peipp, Matthias|Wesch, Daniela | ||||||||||
| PMID: | 29725336 | ||||||||||